findmyKOL
Clinical trialNCT06520345RecruitingPhase 3Interventional

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

SponsorTelix Pharmaceuticals (Innovations) Pty LimitedEnrollment520Metastatic Castration-resistant Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

31 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia
  • Nepean Hospital

    Sydney, New South Wales, Australia

    Dr. Veronica Wong
    Recruiting
  • Westmead Hospital

    Sydney, New South Wales, Australia

    Dr. Tania Moujaber
    Recruiting
  • Wollongong Hospital

    Wollongong, New South Wales, Australia

    Dr. Gary Tincknell
    Recruiting
  • Australian Prostate Centre

    Melbourne, Victoria, Australia

    Prof. Tony Costello
    Recruiting
  • Genesiscare Murdoch

    Perth, Western Australia, Australia

    Dr. Aviral Singh
    Recruiting
  • Mater Health Services Pty Ltd

    Brisbane, Australia

    Niara Oliveira
    Not, yet, recruiting
  • Genesiscare Maitland

    East Maitland, Australia

    Sangeetha Ramanujan
    Recruiting
  • Austin Health

    Heidelberg, Australia

    Recruiting
  • Gensiscare Cabrini

    Malvern, Australia

    Mario Guerrieri
    Recruiting
  • Genesiscare North Adelaide

    North Adelaide, Australia

    Tony Michele
    Recruiting
  • Royal North Shore Hospital

    Saint Leonards, Australia

    Alexander Guminski
    Recruiting
  • Genesiscare Tugun

    Tugun, Australia

    Sagar Ramani
    Recruiting
Canada
  • Initio Medical Group

    Burnaby, Canada

    Recruiting
  • Sunnybrook Research Institute

    Toronto, Canada

    Urban Emmenegger
    Recruiting
New Zealand
  • Auckland City Hospital

    Grafton, Auckland, New Zealand

    Simon Fu
    Recruiting
  • New Zealand Clinical Research - Christchurch

    Christchurch, New Zealand

    Anthony Rahman
    Recruiting
Turkey (Türkiye)
  • Ankara Bilkent City Hospital

    Ankara, Turkey (Türkiye)

    Elif Özdemir
    Not, yet, recruiting
  • Ankara University Cebeci Hospital

    Ankara, Turkey (Türkiye)

    Yuksel Urun
    Recruiting
  • Hacettepe University Medical Faculty

    Ankara, Turkey (Türkiye)

    Murat Bozkurt
    Recruiting
  • Maslak Acibadem Hospital

    Istanbul, Turkey (Türkiye)

    Tevfik F Cermik
    Not, yet, recruiting
United Kingdom
  • University College London Hospitals

    London, United Kingdom

    Ursula McGovern
    Recruiting
  • Genesis Care Windsor

    Windsor, United Kingdom

    Nicola Dallas
    Recruiting
United States
  • Chao Family Comprehensive Cancer Centre

    Orange, California, United States

    Active, not recruiting
  • Biogenix Molecular Llc

    Miami, Florida, United States

    Active, not recruiting
  • United Theranostics

    Glen Burnie, Maryland, United States

    Active, not recruiting
  • Xcancer Omaha

    Omaha, Nebraska, United States

    Active, not recruiting
  • Columbia University Herbert Irving Comphrensive Cancer Center

    New York, New York, United States

    Recruiting
  • University Hospital

    Cleveland, Ohio, United States

    Active, not recruiting
  • Ohsu Knight Cancer Center

    Portland, Oregon, United States

    Active, not recruiting
  • Intermountain Health

    Murray, Utah, United States

    Active, not recruiting
  • Intermountain Health

    Salt Lake City, Utah, United States

    Active, not recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
26 Jul 2024
Primary completion
31 Dec 2027
Completion
31 Dec 2030
Last update posted
18 Jun 2026
Registered enrollment
520
Registry id
NCT06520345

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.